The Fight for Pre-IPO SpaceX: Inside the ETF Battling for Trust

NEW YORK, NY – March 30, 2026 – As whispers of a monumental SpaceX initial public offering value the company at an astronomical $1.75 trillion, a niche exchange-traded fund is making waves by offering everyday investors a ticket to the launch. The ERShares Private-Public Crossover ETF, trading under the ticker XOVR, has positioned itself as a unique gateway for the public to access the kind of pre-IPO shares typically reserved for sovereign wealth funds and Silicon Valley insiders. But as it champions the democratization of finance, the fund finds itself embroiled in a fierce public battle over its structure, transparency, and the very nature of market analysis, raising critical questions for the future of retail investing.

A Retail Ticket to the Final Frontier

For decades, the most explosive growth of transformative companies like SpaceX has occurred while they were still private, leaving retail investors to buy in only after a public offering. ERShares aims to change that paradigm. The XOVR ETF was conceived with a clear mission: to blend the stability of established public companies with the high-growth potential of late-stage private ventures.

"We built XOVR for one reason: to give every investor access to the kind of private market opportunity that has always existed — but never for them," stated Joel Shulman, Ph.D., CFA, the Founder and Chief Investment Officer of ERShares, in a recent press release. "Everything we do is in service of that investor."

The fund's structure is a hybrid. Its foundation is a basket of 30 large-cap public companies, but its main attraction is a sleeve dedicated to private market darlings. Chief among them is SpaceX. As of late March 2026, XOVR holds approximately $205 million in SpaceX exposure. However, it does not hold SpaceX shares directly. Instead, it invests in a Special Purpose Vehicle (SPV)—a separate entity designed to hold interests in private funds that, in turn, hold direct stakes in the space exploration giant. This complex, layered structure is the mechanism that allows a publicly-traded, Nasdaq-listed ETF to offer exposure to an unlisted, highly sought-after private asset.

This structure means any retail investor with a brokerage account can buy shares of XOVR, and by extension, gain a form of exposure to Elon Musk's space venture before its potential IPO, which reports suggest could happen as early as June 2026.

Valuation, Risk, and a Trillion-Dollar Question

The promise of capturing pre-IPO upside is tantalizing, but it comes with a unique set of complexities and risks. The valuation of private companies is more art than science, lacking the daily price discovery of public markets. While ERShares notes it calculates and publishes a Net Asset Value (NAV) daily, it also acknowledges that its internal valuations may differ from external market chatter due to timing, transaction costs, and methodology.

More pointedly, the concentration of SpaceX within the fund has become a significant point of discussion. Research indicates the fund's indirect stake in SpaceX has ballooned to represent over 44% of the ETF's total holdings. This heavy weighting in a single, illiquid private asset represents a substantial concentration risk, tying the fund's fate closely to the fortunes and eventual IPO of SpaceX.

This innovative structure has also attracted regulatory attention. The U.S. Securities and Exchange Commission (SEC) has been increasingly scrutinizing funds that package illiquid assets into liquid, daily-redeemable ETFs. A key rule under the Investment Company Act of 1940 generally limits such funds from holding more than 15% of their assets in illiquid investments. How funds like XOVR manage this limit, maintain daily liquidity for shareholder redemptions, and ensure fair valuation is a central concern for regulators focused on investor protection, especially during periods of market stress.

A War of Words Over Transparency

This backdrop of innovation and risk has set the stage for a contentious public dispute. ERShares has taken the extraordinary step of launching a formal campaign against what it describes as a year-long barrage of misleading commentary from a single, unnamed analyst. The firm alleges the analyst published over 120 posts, articles, and podcast appearances that materially misrepresent the XOVR fund's structure, fees, and disclosures.

"When an analyst publishes an outsized volume of commentary focused on a single fund — around Valentine's Day, New Year's Eve, Christmas Eve — that is not analysis. That is something else entirely," said Eva Ados, Chief Investment Strategist & COO at ERShares. The firm insists that its disclosures are robust and compliant with all SEC requirements, and that investors should rely on official filings rather than what it deems to be misleading third-party characterizations.

ERShares has escalated the conflict beyond words, retaining a Washington, D.C. defamation law firm which has sent formal correspondence to the analyst's employer, Morningstar, Inc. Furthermore, Professor Shulman has filed a formal complaint with the CFA Institute Professional Conduct Division, a serious charge within the financial analysis community. This aggressive defense underscores the high stakes involved in maintaining investor trust, particularly for a novel product operating in a new and complex space. The dispute highlights the critical role—and potential for conflict—of independent analysis in the financial ecosystem.

The New Frontier of Investing

The story of XOVR and its battle for legitimacy is a microcosm of a much broader trend reshaping the investment landscape. With companies staying private longer and achieving massive valuations before ever hitting the public market, there is immense demand for products that can bridge the gap. A wave of innovation has produced various solutions, from interval funds with limited liquidity to other public-private crossover funds like the ARK Venture Fund.

What sets XOVR apart is its attempt to deliver this exposure within the familiar, daily-liquid, and highly regulated ETF wrapper, all without requiring investors to meet the high net worth thresholds of an accredited investor. This ambition places it on the cutting edge of financial product design, but also on the front lines of regulatory and market scrutiny.

As investors weigh the allure of getting in early on the next historic IPO against the inherent risks of illiquidity, valuation complexity, and concentration, the market for such products will continue to evolve. The journey of the XOVR ETF, with its promise of access and its public fight for trust, serves as a crucial case study in the ongoing quest to democratize finance and the profound challenges that lie on that path. The outcome of this convergence of innovation, risk, and regulation will likely define the boundaries of retail investing for years to come.